Orphenadrine Citrate, Aspirin and Caffeine 25 mg/385 mg/30 mg and Orphenadrine Citrate, Aspirin and Caffeine 50 mg/770 mg/60 mg Tablets are indicated in:

1. Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.

2. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.

The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. Orphenadrine Citrate, Aspirin and Caffeine 25 mg/385 mg/30 mg and Orphenadrine Citrate, Aspirin and Caffeine 50 mg/770 mg/60 mg Tablets do not directly relax tense skeletal muscles in man.

Orphenadrine Citrate, Aspirin and Caffeine 25 mg/385 mg/30 mg Tablets: Adults 1 to 2 tablets 3 to 4 times daily.

Orphenadrine Citrate, Aspirin and Caffeine 50 mg/770 mg/60 mg Tablets: Adults ½ to 1 tablet 3 to 4 times daily.

Orphenadrine Citrate, Aspirin and Caffeine 25 mg/385 mg/30 mg Tablets are green/ white, round, bilayered, compressed, unscored, engraved INV over 265 on one side and are supplied as follows:

NDC 62269-265-24 in bottles of 100 tablets

NDC 62269-265-29 in bottles of 500 tablets

Orphenadrine Citrate, Aspirin and Caffeine 50 mg/770 mg/60 mg Tablets are green/white, capsule shaped, bi-layered, compressed, engraved INV to the left and 266 to the right of the bisect on one side and are supplied as follows:

NDC 62269-266-24 in bottles of 100 tablets

NDC 62269-266-29 in bottles of 500 tablets.

Store below 30°C (86°F). Protect from moisture.

Dispense in a tight, light-resistant container as defined in the USP.

CAUTION: Federal law prohibits dispensing without prescription.

Bookmark this page: